v3.22.2.2

Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2022
Segment Information |
Segment Information | Note 16. Segment Information As a result of the Company’s transition to a pure-play health and wellness services company, the Company currently has four reportable operating segments: XpresSpa, XpresTest, Treat and HyperPointe, acquired in January 2022. The Company analyzes the results of the Company’s business through the four reportable segments. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment provides access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place, as well as book appointments in the Company’s on-site wellness centers as they reopen. The HyperPointe segment provides a broad range of service and support options for its customers, including technical support services and advanced services. The chief operating decision maker evaluates the operating results and performance of the Company’s segments through operating income. Expenses that can be specifically identified with a segment have been included as deductions in determining operating income. Any remaining expenses and other charges are included in Corporate and Other. ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended
​ | ​ | September 30,
​ |  | 2022 |  | 2021
Revenue |  | ​ |  |  | ​ |
XpresSpa | ​ | $ | 3,557 | ​ | $ | 1,416
XpresTest | ​ | ​ | 6,079 | ​ | ​ | 25,351
Treat | ​ | ​ | 425 | ​ | ​ | —
HyperPointe | ​ | ​ | 675 | ​ | ​ | —
Corporate and other | ​ |  | — | ​ |  | —
Total revenue | ​ | $ | 10,736 | ​ | $ | 26,767
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Operating income (loss) | ​ |  |  | ​ |  |
XpresSpa | ​ | $ | (2,508) | ​ | $ | (1,595)
XpresTest | ​ | ​ | (1,692) | ​ | ​ | 12,015
Treat | ​ | ​ | (1,282) | ​ | ​ | (2,305)
HyperPointe | ​ | ​ | (193) | ​ | ​ | —
Corporate and other | ​ |  | (1,979) | ​ |  | (1,058)
Total operating (loss) income | ​ | $ | (7,654) | ​ | $ | 7,057
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation & Amortization | ​ | ​ | ​ | ​ | ​ | ​
XpresSpa | ​ | $ | 364 | ​ | $ | 340
XpresTest | ​ |  | 576 | ​ |  | 509
Treat | ​ | ​ | 520 | ​ | ​ | —
HyperPointe | ​ | ​ | 86 | ​ | ​ | —
Corporate and other | ​ |  | 18 | ​ |  | 3
Total Depreciation & Amortization | ​ | $ | 1,564 | ​ | $ | 852
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the nine months ended
​ | ​ | September 30,
​ |  | 2022 |  | 2021
Revenue |  | ​ |  |  | ​ |
XpresSpa | ​ | $ | 9,490 | ​ | $ | 2,172
XpresTest | ​ | ​ | 35,928 | ​ | ​ | 42,199
Treat | ​ | ​ | 1,110 | ​ | ​ | —
HyperPointe | ​ | ​ | 1,853 | ​ | ​ | —
Corporate and other | ​ |  | — | ​ |  | —
Total revenue | ​ | $ | 48,381 | ​ | $ | 44,371
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Operating loss | ​ |  |  | ​ |  |
XpresSpa | ​ | $ | (8,921) | ​ | $ | (4,828)
XpresTest | ​ | ​ | 2,576 | ​ | ​ | 14,597
Treat | ​ | ​ | (4,038) | ​ | ​ | (4,115)
HyperPointe | ​ | ​ | (745) | ​ | ​ | —
Corporate and other | ​ |  | (6,744) | ​ |  | (3,719)
Total operating (loss) income | ​ | $ | (17,872) | ​ | $ | 1,935
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation & Amortization | ​ | ​ | ​ | ​ | ​ | ​
XpresSpa | ​ | $ | 1,065 | ​ | $ | 931
XpresTest | ​ |  | 1,711 | ​ |  | 1,604
Treat | ​ | ​ | 1,287 | ​ | ​ | —
HyperPointe | ​ | ​ | 243 | ​ | ​ | —
Corporate and other | ​ |  | 23 | ​ |  | 7
Total depreciation & amortization | ​ | $ | 4,329 | ​ | $ | 2,542
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Capital Expenditures | ​ | ​ | ​ | ​ | ​ | ​
XpresSpa | ​ | $ | 1,413 | ​ | $ | 706
XpresTest | ​ |  | 675 | ​ |  | 3,984
Treat | ​ | ​ | 3,329 | ​ | ​ | —
HyperPointe | ​ | ​ | — | ​ | ​ | —
Corporate and other | ​ |  | 55 | ​ |  | 77
Total capital expenditures | ​ | $ | 5,472 | ​ | $ | 4,767
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | December 31,
​ | ​ | 2022 | ​ | 2021
Long-lived Assets | ​ | ​ | ​ | ​ | ​ | ​
XpresSpa | ​ | $ | 14,203 | ​ | ​ | 8,419
XpresTest | ​ |  | 112 | ​ | ​ | 2,246
Treat | ​ | ​ | 6,280 | ​ | ​ | 2,700
HyperPointe | ​ |  | 123 | ​ | ​ | —
Corporate and other | ​ |  | 522 | ​ | ​ | 1,132
Total long-lived Assets | ​ | $ | 21,240 | ​ | $ | 14,497
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | December 31,
​ | ​ | 2022 |  | 2021
Assets | ​ |  |  | ​ |  |
XpresSpa | ​ | $ | 21,348 | ​ | $ | 12,351
XpresTest | ​ |  | 5,356 | ​ |  | 19,349
Treat | ​ | ​ | 9,822 | ​ | ​ | 5,918
HyperPointe | ​ | ​ | 7,126 | ​ | ​ | —
Corporate and other | ​ |  | 41,324 | ​ |  | 89,648
Total assets | ​ | $ | 84,976 | ​ | $ | 127,266
​ ​

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration